SmartManage Stress Management for HIV+ Cancer Survivors
- Conditions
- StressHivCancer
- Interventions
- Behavioral: SmartManage for HIV+ cancer survivorsBehavioral: Educational Control
- Registration Number
- NCT04544917
- Lead Sponsor
- University of Miami
- Brief Summary
The purpose of this study is to design and refine a web-based platform developed for managing symptom burden in men who have sex who are HIV+ cancer survivors.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- Male
- Target Recruitment
- 50
- Age: 18 years or older
- Fluent in English
- Have evidence of at least one form of non-metastatic solid tumor cancer or blood cancer
- Be at least 30 days post active primary cancer treatment
- Self identify as a sexual minority cisgender man
- Self-report having been diagnosed with HIV
- Have reliable access to a computer/device with internet accessibility
- Have had one of the following exclusionary cancer types: Non-melanoma skin cancer, brain cancer, eye cancer, history of some form of pediatric cancer (if that is participant's only cancer diagnosis)
- History of advanced (metastatic) cancer of any type
- Inpatient treatment for severe mental illness in the past 12 months and/or suicidality of moderate or greater risk
- Appears actively intoxicated or otherwise unable to provide full informed consent
- Have any other medical condition resulting in predicted live expectancy of less than 12 months
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description SmartManage Group SmartManage for HIV+ cancer survivors Participants in this group will receive ten 90-minute weekly therapist delivered SmartManage group sessions via video conference. Participants will have access to the SmartManage web platform, which will also guide the live intervention sessions. Educational Control Group Educational Control Participants in this group will view ten weekly control content video recorded sessions.
- Primary Outcome Measures
Name Time Method Proportion of eligible SMM that agree to participate Up to one year Feasibility of the intervention will be reported as the proportion of eligible sexual minority men (SMM) who agree to participate versus decline
- Secondary Outcome Measures
Name Time Method USE Questionnaire Scores Week 10 Acceptability of the intervention will be reported as Usefulness, Satisfaction and Ease of Use (USE) Questionnaire Scores. USE is a 30-item questionnaire with a total score ranging from 30-240 with the higher score indicating greater acceptability of the intervention.
Trial Locations
- Locations (1)
University of Miami
🇺🇸Miami, Florida, United States